<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>医疗器械监管 on AI内参</title>
    <link>https://www.neican.ai/tags/%E5%8C%BB%E7%96%97%E5%99%A8%E6%A2%B0%E7%9B%91%E7%AE%A1/</link>
    <description>Recent content in 医疗器械监管 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Mon, 02 Mar 2026 08:10:05 +0800</lastBuildDate>
    <atom:link href="https://www.neican.ai/tags/%E5%8C%BB%E7%96%97%E5%99%A8%E6%A2%B0%E7%9B%91%E7%AE%A1/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>药片还是芯片？算法时代的“弗洛伊德”</title>
      <link>https://www.neican.ai/insights/article-20260302081005145-0/</link>
      <pubDate>Mon, 02 Mar 2026 08:10:05 +0800</pubDate>
      <guid>https://www.neican.ai/insights/article-20260302081005145-0/</guid>
      <description>本文分析了望里科技如何利用生成式AI与临床数据构建精神心理诊疗的竞争护城河。随着首个抗抑郁数字医疗三类证的获批，AI医疗正从低门槛的健康管理转向严谨的临床治疗，预示着精神健康产业规模化商业变现的新窗口已经开启。</description>
    </item>
  </channel>
</rss>
